TrianglePUBLICATIONS · 38954782
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Nov
- First author
- Meyers PA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Meyers PA
- type
- Author
- name
- Federman N
- type
- Author
- name
- Daw N
- type
- Author
- name
- Anderson PM
- type
- Author
- name
- Davis LE
- type
- Author
- name
- Kim A
- type
- Author
- name
- Macy ME
- type
- Author
- name
- Pietrofeso A
- type
- Author
- name
- Ratan R
- type
- Author
- name
- Riedel RF
- type
- Author
- name
- Trucco M
- type
- Author
- name
- Breitmeyer JB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Meyers PA
- type
- Author
- name
- Federman N
- type
- Author
- name
- Daw N
- type
- Author
- name
- Anderson PM
- type
- Author
- name
- Davis LE
- type
- Author
- name
- Kim A
- type
- Author
- name
- Macy ME
- type
- Author
- name
- Pietrofeso A
- type
- Author
- name
- Ratan R
- type
- Author
- name
- Riedel RF
- type
- Author
- name
- Trucco M
- type
- Author
- name
- Breitmeyer JB
- type
- Author
- bibliography ids
- nci-bib-522ee93b564eb035036cfca7
- book metadata
- content sha256
- cc5a9b2a9f2eab89ca9e804959b2eff056206c62f36c25af44fadcec2924b88c
- document type
- citation
- dois
- 10.1200/JCO.24.00020
- electronic publication date
- display
- 2024 Jul 2
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38954782
- immutable id
- pubmed:38954782@cc5a9b2a9f2eab89ca9e804959b2eff056206c62f36c25af44fadcec2924b88c
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 31
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3725-3734
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38954782
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- d4c3c710ab06eaa2356e659e8f685c86c5df09ef3f317a63637da2993fa74b95
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2024 Nov
- precision
- month
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase I
- Multicenter Study
- Clinical Trial, Phase II
- Research Support, Non-U.S. Gov't
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Preserved source evidence · Not medical advice